<VariationArchive RecordType="classified" VariationID="10532" VariationName="NM_000292.3(PHKA2):c.421_423del (p.Phe141del)" VariationType="Deletion" Accession="VCV000010532" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-04-25" DateCreated="2014-05-05" MostRecentSubmission="2014-05-05">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="25571" VariationID="10532">
      <GeneList>
        <Gene Symbol="PHKA2" FullName="phosphorylase kinase regulatory subunit alpha 2" GeneID="5256" HGNC_ID="HGNC:8926" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xp22.13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="18892298" stop="18984114" display_start="18892298" display_stop="18984114" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="18910415" stop="19002479" display_start="18910415" display_stop="19002479" Strand="-" />
          </Location>
          <OMIM>300798</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000292.3(PHKA2):c.421_423del (p.Phe141del)</Name>
      <CanonicalSPDI>NC_000023.11:18951134:GAAGA:GA</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xp22.13</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="18951135" stop="18951137" display_start="18951135" display_stop="18951137" variantLength="3" positionVCF="18951134" referenceAlleleVCF="GGAA" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="18969253" stop="18969255" display_start="18969253" display_stop="18969255" variantLength="3" positionVCF="18969252" referenceAlleleVCF="GGAA" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>F141del</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.18969255_18969257del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.18969255_18969257del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.18951137_18951139del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.18951137_18951139del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_016622.1" sequenceAccession="NG_016622" sequenceVersion="1" change="g.38226_38228del">
            <Expression>NG_016622.1:g.38226_38228del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000292.3" sequenceAccession="NM_000292" sequenceVersion="3" change="c.421_423del" MANESelect="true">
            <Expression>NM_000292.3:c.421_423del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000283.1" sequenceAccession="NP_000283" sequenceVersion="1" change="p.Phe141del">
            <Expression>NP_000283.1:p.Phe141del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA255294" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="300798.0006" DB="OMIM" />
        <XRef Type="rs" ID="587776732" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000292.3(PHKA2):c.421_423del (p.Phe141del) AND Glycogen storage disease IXa1" Accession="RCV000011278" Version="6">
        <ClassifiedConditionList TraitSetID="7454">
          <ClassifiedCondition DB="MedGen" ID="C3694531">Glycogen storage disease IXa1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1995-02-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="1995-02-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2014-05-05" MostRecentSubmission="2014-05-05">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">7847371</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="7454" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2237" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">LIVER GLYCOGENOSIS, X-LINKED, TYPE I</ElementValue>
                <XRef Type="MIM" ID="306000" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Glycogen storage disease IXa1</ElementValue>
                <XRef ID="MONDO:0010598" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">GSD VIII</ElementValue>
                <XRef Type="MIM" ID="306000" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glycogen storage disease 8</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glycogenosis type 8</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hepatic phosphorylase kinase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Phosphorylase kinase deficiency of liver</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">PYKL</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">GSD8</ElementValue>
                <XRef Type="MIM" ID="306000" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">GSD9A1</ElementValue>
                <XRef Type="MIM" ID="306000" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">XLG1</ElementValue>
                <XRef Type="MIM" ID="306000" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">XLG2</ElementValue>
                <XRef ID="306000" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Phosphorylase kinase (PhK) deficiency causing glycogen storage disease type IX (GSD IX) results from deficiency of the enzyme phosphorylase b kinase, which has a major regulatory role in the breakdown of glycogen. The two types of PhK deficiency are liver PhK deficiency (characterized by early childhood onset of hepatomegaly and growth restriction, and often, but not always, fasting ketosis and hypoglycemia) and muscle PhK deficiency, which is considerably rarer (characterized by any of the following: exercise intolerance, myalgia, muscle cramps, myoglobinuria, and progressive muscle weakness). While symptoms and biochemical abnormalities of liver PhK deficiency were thought to improve with age, it is becoming evident that patients need to be monitored for long-term complications such as liver fibrosis and cirrhosis.</Attribute>
                <XRef ID="NBK55061" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">21634085</ID>
                <ID Source="BookShelf">NBK55061</ID>
              </Citation>
              <XRef ID="264580" DB="Orphanet" />
              <XRef ID="C3694531" DB="MedGen" />
              <XRef ID="MONDO:0010598" DB="MONDO" />
              <XRef Type="MIM" ID="306000" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="31506" SubmissionDate="2014-04-29" DateLastUpdated="2014-05-05" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="300798.0006_GLYCOGEN STORAGE DISEASE, TYPE IXa1" title="PHKA2, 3-BP DEL, 419TCT_GLYCOGEN STORAGE DISEASE, TYPE IXa1" />
        <ClinVarAccession Accession="SCV000031506" DateUpdated="2014-05-05" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1995-02-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a Dutch boy with GSD type IXa1 (GSD9A1; 306000), van den Berg et al. (1995) found a 3-bp deletion (419_421), resulting in deletion of phenylalanine-141 from the gene product. The same deletion was found in the PHKA2 coding sequence from lymphocytes of the patient's mother in heterozygous state. This phenylalanine is a highly conserved amino acid between species.</Attribute>
              <Citation>
                <ID Source="PubMed">7847371</ID>
              </Citation>
              <XRef DB="OMIM" ID="306000" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PHKA2" />
          </GeneList>
          <Name>PHKA2, 3-BP DEL, 419TCT</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">3-BP DEL, 419TCT</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="300798.0006" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">GLYCOGEN STORAGE DISEASE, TYPE IXa1</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="31506" TraitType="Disease" MappingType="Name" MappingValue="GLYCOGEN STORAGE DISEASE, TYPE IXa1" MappingRef="Preferred">
        <MedGen CUI="C3694531" Name="Glycogen storage disease IXa1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

